• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Stada is the worst possible acquirer for UPSA ( BMS OTC in France )

anonymous

Guest
Poor french BMS employees

Stada is owned by 2 cash driven PE's Cinven and Bain.
Cinven and Bain are claiming to have $100 mio in synergies through cost cuttings in post acquisition.
This is going to be a blood bath for all our colleagues.
Mr Caforio if you have decided to sell UPSA ( and we hope not ) please select an industrial partner with value and growth perpectives for our respectful BMS division UPSA.
We have believed in BMS values please do not trash us without consideration
 

<